NO20021410D0 - Forebygging og behandling av blodkoagulasjons-relaterte sykdommer - Google Patents
Forebygging og behandling av blodkoagulasjons-relaterte sykdommerInfo
- Publication number
- NO20021410D0 NO20021410D0 NO20021410A NO20021410A NO20021410D0 NO 20021410 D0 NO20021410 D0 NO 20021410D0 NO 20021410 A NO20021410 A NO 20021410A NO 20021410 A NO20021410 A NO 20021410A NO 20021410 D0 NO20021410 D0 NO 20021410D0
- Authority
- NO
- Norway
- Prior art keywords
- prevention
- treatment
- related diseases
- blood coagulation
- diseases
- Prior art date
Links
- 201000010099 disease Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 230000023555 blood coagulation Effects 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 101000635804 Homo sapiens Tissue factor Proteins 0.000 abstract 2
- 201000005665 thrombophilia Diseases 0.000 abstract 2
- 200000000007 Arterial disease Diseases 0.000 abstract 1
- 206010003178 Arterial thrombosis Diseases 0.000 abstract 1
- 206010020880 Hypertrophy Diseases 0.000 abstract 1
- 206010047249 Venous thrombosis Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 230000002085 persistent effect Effects 0.000 abstract 1
- 230000003449 preventive effect Effects 0.000 abstract 1
- 229940124597 therapeutic agent Drugs 0.000 abstract 1
- 210000004231 tunica media Anatomy 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0271—Chimeric vertebrates, e.g. comprising exogenous cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5094—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for blood cell populations
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2207/00—Modified animals
- A01K2207/15—Humanized animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2227/00—Animals characterised by species
- A01K2227/10—Mammal
- A01K2227/106—Primate
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2267/00—Animals characterised by purpose
- A01K2267/03—Animal model, e.g. for test or diseases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Zoology (AREA)
- Analytical Chemistry (AREA)
- Pathology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Environmental Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Animal Behavior & Ethology (AREA)
- General Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Ecology (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP28219299 | 1999-10-01 | ||
JP28218899 | 1999-10-01 | ||
JP28216799 | 1999-10-01 | ||
JP28213499 | 1999-10-01 | ||
JP28184399 | 1999-10-01 | ||
JP28212099 | 1999-10-01 | ||
PCT/JP2000/006802 WO2001024626A1 (fr) | 1999-10-01 | 2000-09-29 | Prevention et traitement de maladies associees a la coagulation sanguine |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20021410D0 true NO20021410D0 (no) | 2002-03-21 |
NO20021410L NO20021410L (no) | 2002-05-24 |
Family
ID=27554423
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20021410A NO20021410L (no) | 1999-10-01 | 2002-03-21 | Forebygging og behandling av blodkoagulasjons-relaterte sykdommer |
Country Status (18)
Country | Link |
---|---|
US (2) | US8062638B1 (no) |
EP (2) | EP2351483A1 (no) |
JP (1) | JP3859512B2 (no) |
KR (1) | KR20030008205A (no) |
AT (1) | ATE498305T1 (no) |
AU (1) | AU7450600A (no) |
BR (1) | BR0014667A (no) |
CA (1) | CA2388408A1 (no) |
CZ (1) | CZ20021035A3 (no) |
DE (1) | DE60045638D1 (no) |
DK (1) | DK1222854T3 (no) |
HU (1) | HUP0203486A2 (no) |
IL (1) | IL148980A0 (no) |
MX (1) | MXPA02003278A (no) |
NO (1) | NO20021410L (no) |
PL (1) | PL354961A1 (no) |
SK (1) | SK4442002A3 (no) |
WO (1) | WO2001024626A1 (no) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6703494B2 (en) | 2000-03-16 | 2004-03-09 | Genentech, Inc. | Anti-tissue factor antibodies with enhanced anticoagulant potency |
EP1374896A4 (en) * | 2001-03-26 | 2005-04-06 | Koji Suzuki | MEANS TO IMPROVE THE FLUID CHARACTERISTICS OF BLOOD |
JP4683821B2 (ja) | 2001-05-18 | 2011-05-18 | 中外製薬株式会社 | ヒト組織因子を産生するノックイン非ヒト動物 |
IL160998A0 (en) * | 2001-10-02 | 2004-08-31 | Novo Nordisk As | Human tissue factor antibodies |
US20060233786A1 (en) * | 2002-05-23 | 2006-10-19 | Chugai Seiyaku Kabushiki Kaisha | Agent neutralizint tissue factor inhibitor and agent neutralizing activated blood coagulation factor viii preparation |
AU2004216298B2 (en) * | 2003-02-28 | 2009-04-23 | Chugai Seiyaku Kabushiki Kaisha | Stabilized protein-containing formulations |
US7605235B2 (en) | 2003-05-30 | 2009-10-20 | Centocor, Inc. | Anti-tissue factor antibodies and compositions |
EP1939218A1 (en) * | 2006-12-29 | 2008-07-02 | Thrombotargets Europe, S.L. | Microvesicles derived from recombinant yeast having haemostatic activities and uses thereof |
US8722044B2 (en) | 2011-03-15 | 2014-05-13 | Janssen Biotech, Inc. | Human tissue factor antibody and uses thereof |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58201994A (ja) | 1982-05-21 | 1983-11-25 | Hideaki Hagiwara | 抗原特異的ヒト免疫グロブリンの生産方法 |
US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
IE81149B1 (en) | 1987-02-12 | 2000-05-03 | Genentech Inc | Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
US5223427A (en) | 1987-03-31 | 1993-06-29 | The Scripps Research Institute | Hybridomas producing monoclonal antibodies reactive with human tissue-factor glycoprotein heavy chain |
AU1948388A (en) * | 1987-06-12 | 1989-01-04 | Mount Sinai School Of Medicine Of The City University Of New York, The | Cloning and expression of human tissue factor |
KR100272077B1 (ko) | 1990-08-29 | 2000-11-15 | 젠팜인터내셔날,인코포레이티드 | 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물 |
AU668349B2 (en) | 1991-04-25 | 1996-05-02 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human interleukin 6 receptor |
US5346991A (en) * | 1991-06-13 | 1994-09-13 | Genentech, Inc. | Tissue factor mutants useful for the treatment of myocardial infarction and coagulopathic disorders |
CA2124967C (en) | 1991-12-17 | 2008-04-08 | Nils Lonberg | Transgenic non-human animals capable of producing heterologous antibodies |
JPH07509137A (ja) | 1992-07-24 | 1995-10-12 | セル ジェネシス,インク. | 異種抗体の生産 |
US5648267A (en) | 1992-11-13 | 1997-07-15 | Idec Pharmaceuticals Corporation | Impaired dominant selectable marker sequence and intronic insertion strategies for enhancement of expression of gene product and expression vector systems comprising same |
US5879677A (en) * | 1992-12-09 | 1999-03-09 | The Scripps Research Institute | Method for inhibition of cerebral tissue factor mediated reperfusion damage |
EP0754225A4 (en) | 1993-04-26 | 2001-01-31 | Genpharm Int | HETEROLOGIC ANTIBODY-PRODUCING TRANSGENIC NON-HUMAN ANIMALS |
JP3865418B2 (ja) | 1994-07-13 | 2007-01-10 | 中外製薬株式会社 | ヒトインターロイキン−8に対する再構成ヒト抗体 |
WO1996002576A1 (fr) | 1994-07-13 | 1996-02-01 | Chugai Seiyaku Kabushiki Kaisha | Anticorps humain reconstitue contre l'interleukine-8 humaine |
KR20050085971A (ko) | 1995-04-27 | 2005-08-29 | 아브게닉스, 인크. | 면역화된 제노마우스 유래의 인간 항체 |
AU2466895A (en) | 1995-04-28 | 1996-11-18 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
EP0962467A4 (en) | 1996-09-26 | 2002-10-30 | Chugai Pharmaceutical Co Ltd | ANTIBODIES AGAINST HUMAN PARATHORMON RELATED PEPTIDES |
US5986065A (en) | 1997-03-10 | 1999-11-16 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
IL138801A0 (en) * | 1998-04-03 | 2001-10-31 | Chugai Pharmaceutical Co Ltd | Humanized antibody against human tissue factor and process for the preparation thereof |
EP0987274A1 (en) * | 1998-09-15 | 2000-03-22 | Hoechst Marion Roussel Deutschland GmbH | Factor VIIa Inhibitors |
-
2000
- 2000-09-29 KR KR1020027004130A patent/KR20030008205A/ko not_active Application Discontinuation
- 2000-09-29 EP EP10180790A patent/EP2351483A1/en not_active Withdrawn
- 2000-09-29 IL IL14898000A patent/IL148980A0/xx unknown
- 2000-09-29 BR BR0014667-6A patent/BR0014667A/pt not_active IP Right Cessation
- 2000-09-29 PL PL00354961A patent/PL354961A1/xx unknown
- 2000-09-29 JP JP2001527640A patent/JP3859512B2/ja not_active Expired - Fee Related
- 2000-09-29 CZ CZ20021035A patent/CZ20021035A3/cs unknown
- 2000-09-29 EP EP00963006A patent/EP1222854B1/en not_active Expired - Lifetime
- 2000-09-29 SK SK444-2002A patent/SK4442002A3/sk unknown
- 2000-09-29 WO PCT/JP2000/006802 patent/WO2001024626A1/ja not_active Application Discontinuation
- 2000-09-29 HU HU0203486A patent/HUP0203486A2/hu unknown
- 2000-09-29 CA CA002388408A patent/CA2388408A1/en not_active Abandoned
- 2000-09-29 AU AU74506/00A patent/AU7450600A/en not_active Abandoned
- 2000-09-29 MX MXPA02003278A patent/MXPA02003278A/es unknown
- 2000-09-29 DE DE60045638T patent/DE60045638D1/de not_active Expired - Lifetime
- 2000-09-29 AT AT00963006T patent/ATE498305T1/de not_active IP Right Cessation
- 2000-09-29 US US10/089,501 patent/US8062638B1/en not_active Expired - Fee Related
- 2000-09-29 DK DK00963006.2T patent/DK1222854T3/da active
-
2002
- 2002-03-21 NO NO20021410A patent/NO20021410L/no not_active Application Discontinuation
-
2011
- 2011-10-04 US US13/252,455 patent/US20120073002A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
MXPA02003278A (es) | 2002-09-02 |
DE60045638D1 (de) | 2011-03-31 |
NO20021410L (no) | 2002-05-24 |
BR0014667A (pt) | 2002-07-02 |
JP3859512B2 (ja) | 2006-12-20 |
HUP0203486A2 (hu) | 2003-02-28 |
KR20030008205A (ko) | 2003-01-24 |
US8062638B1 (en) | 2011-11-22 |
CZ20021035A3 (cs) | 2002-08-14 |
PL354961A1 (en) | 2004-03-22 |
ATE498305T1 (de) | 2011-03-15 |
US20120073002A1 (en) | 2012-03-22 |
DK1222854T3 (da) | 2011-03-14 |
EP1222854A1 (en) | 2002-07-17 |
AU7450600A (en) | 2001-05-10 |
CA2388408A1 (en) | 2001-04-12 |
IL148980A0 (en) | 2002-11-10 |
EP1222854A4 (en) | 2006-07-05 |
EP1222854B1 (en) | 2011-02-16 |
WO2001024626A1 (fr) | 2001-04-12 |
EP2351483A1 (en) | 2011-08-03 |
SK4442002A3 (en) | 2003-04-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE302599T1 (de) | Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege | |
AU2406402A (en) | Substituted benzene derivatives or salts thereof | |
MXPA03010085A (es) | Composiciones y su uso en la hiperplasia. | |
ATE417551T1 (de) | Bioaktive okklusionsspirale | |
WO2004028570A3 (en) | A method for treating severe tinnitus | |
CY1110894T1 (el) | Μεθοδοι για θεραπεια ή προληψη αγγειακης φλεγμονης χρησιμοποιωντας αναστολεα (-εις) απορροφησης στερολης | |
EA200100572A1 (ru) | Способ применения ингибитора циклооксигеназы-2 и одного или нескольких противоопухолевых лекарственных средств в качестве комбинированного способа лечебного воздействия при лечении неоплазии | |
NO20034204D0 (no) | Farmasöytiske kombinasjoner til behandling av kreft | |
WO2004024093A3 (en) | Device and method for treating restenosis | |
IL91796A0 (en) | Pharmaceutical preparations comprising gamma-interferon | |
WO2003007921A3 (en) | Use of rhein or diacerhein compounds for the treatment or prevention of vascular diseases | |
NO20021410D0 (no) | Forebygging og behandling av blodkoagulasjons-relaterte sykdommer | |
DE60020681D1 (de) | Zusammensetzungen und verfahren zur verbesserung der integrität von angegriffenen körperpassagewegen und höhlen | |
FI952593A (fi) | Hyytymistä estävä aine | |
WO2000071716A3 (en) | Vascular endothelial growth factor dimers | |
WO2002070011A3 (en) | Treatment of ppar mediated diseases | |
EP0950416A4 (en) | Preventive and / or therapeutic agent against cachexia | |
EP1417971A3 (en) | Use of an angiogenic factor for the treatment of microvascular angiopathies | |
WO2001096398A3 (en) | Uncoupling proteins as targets for the treatment of heart failure | |
DE60305592D1 (de) | Liposomenhaltiges Mittel zur Behandlung Gefässerkrankungen | |
EP1829535A3 (en) | Tissue factor antagonists and methods of use thereof | |
AU2002305628A1 (en) | Medicated stents for the treatment of vascular disease | |
UA29154A (uk) | Спосіб лікування хронічного остеомієліту |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |